Authors:
Dittadi, R
Meo, S
Fabris, F
Gasparini, G
Contri, D
Medici, M
Gion, M
Citation: R. Dittadi et al., Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments, INT J B MAR, 16(2), 2001, pp. 87-96
Authors:
Gasparini, G
Toi, M
Biganzoli, E
Dittadi, R
Fanelli, M
Morabito, A
Boracchi, P
Gion, M
Citation: G. Gasparini et al., Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis, ONCOL-BASEL, 60(1), 2001, pp. 72-80
Authors:
Salbe, C
Trevisiol, C
Ferruzzi, E
Mancuso, T
Nascimbeni, R
Di Fabio, F
Salerni, B
Dittadi, R
Citation: C. Salbe et al., Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients, INT J B MAR, 15(4), 2000, pp. 300-307
Authors:
Gion, M
Boracchi, P
Dittadi, R
Biganzoli, E
Peloso, L
Gatti, C
Paccagnella, A
Rosabian, A
Vinante, O
Meo, S
Citation: M. Gion et al., Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possiblyassociated with apoptosis, BREAST CANC, 59(3), 2000, pp. 211-221
Authors:
Gasparini, G
Toi, M
Miceli, R
Vermeulen, PB
Dittadi, R
Biganzoli, E
Morabito, A
Fanelli, M
Gatti, C
Suzuki, H
Tominaga, T
Dirix, LY
Gion, M
Citation: G. Gasparini et al., Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy, CA J SCI AM, 5(2), 1999, pp. 101-111
Authors:
Toi, M
Gion, M
Saji, H
Asano, M
Dittadi, R
Gilberti, S
Locopo, N
Gasparini, G
Citation: M. Toi et al., Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma, INT J ONCOL, 15(6), 1999, pp. 1169-1175